Key contribution of CPEB4-mediated translational control to cancer progression

dc.contributor.authorOrtiz-Zapater, Elenaen
dc.contributor.authorPineda, Daviden
dc.contributor.authorMartinez-Bosch, Neusen
dc.contributor.authorFernandez-Miranda, Gonzaloen
dc.contributor.authorIglesias, Maren
dc.contributor.authorAlameda, Francescen
dc.contributor.authorMoreno, Mireiaen
dc.contributor.authorEliscovich, Carolinaen
dc.contributor.authorEyras, Eduardoen
dc.contributor.authorReal, Francisco X.en
dc.contributor.authorMendez, Raulen
dc.contributor.authorNavarro, Pilaren
dc.date.accessioned2025-12-19T18:40:32Z
dc.date.available2025-12-19T18:40:32Z
dc.date.issued2012en
dc.description.abstractMalignant transformation, invasion and angiogenesis rely on the coordinated reprogramming of gene expression in the cells from which the tumor originated. Although deregulated gene expression has been extensively studied at genomic and epigenetic scales, the contribution of the regulation of mRNA-specific translation to this reprogramming is not well understood. Here we show that cytoplasmic polyadenylation element binding protein 4 (CPEB4), an RNA binding protein that mediates meiotic mRNA cytoplasmic polyadenylation and translation, is overexpressed in pancreatic ductal adenocarcinomas and glioblastomas, where it supports tumor growth, vascularization and invasion. We also show that, in pancreatic tumors, the pro-oncogenic functions of CPEB4 originate in the translational activation of mRNAs that are silenced in normal tissue, including the mRNA of tissue plasminogen activator, a key contributor to pancreatic ductal adenocarcinoma malignancy. Taken together, our results document a key role for post-transcriptional gene regulation in tumor development and describe a detailed mechanism for gene expression reprogramming underlying malignant tumor progression.en
dc.description.sponsorshipThe authors acknowledge F. Gebauer, S. Aznar-Benitah, A. Garcia de Herreros and J. Valcarcel for critical comments on the manuscript and for other valuable contributions. We also thank S. Hahn (Department of Molecular GI-Oncology, University of Bochum, Germany) and M. Buchholz (Department of Gastroenterology, Endocrinology and Metabolism, Philipps-University of Marburg, Marburg, Germany) for providing normal pancreas RNA, O. Casanovas (Translational Research Laboratory, Catalan Institute of Oncology (ICO-Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain) for his help with the T98G nude mice injections, J. R. Gonzalez-Vallinas (Computational Genomics Group, Universitat Pompeu Fabra, Parc de Recerca Biomedica de Barcelona (PRBB)) for assistance with Gene Ontology tools and E. Castillo from the Ultrasequencing Unit (Centre for Gcnomic Regulation, PRBB), S. Mojal from the Statistics Unit (IMIM, PRBB) and T. Lobato from the Histopathological Unit (IMIM, PRBB) for technical assistance. This work was funded by the research grants Instituto de Salud Carlos-Fondos Europeos de Desarrollo Regional (FEDER) (PI080421) from the Ministerio de Ciencia e Innovacion (MICINN) and grants from Fundacio La MaratoTV3 (051110), the American Institute for Cancer Research (AICR) (11-0086) and Generalitat de Catalunya (2009SGR1409) to P.N.; grants BFU2008-02373 and Consolider RNAREG CSD2009-00080 from the MICINN and grants from Fundacio La MaratoTV3 (051110), AICR (11-0086) and Generalitat de Catalunya (2009SGR1436) to R.M.; grant SAF2007-60860 and Consolider ONCOBIO from the MICINN and a grant from the VI EU Framework Programme MolDiag-PaCa project to F.X.R.; grants Consolider RNAREG CSD2009-00080 and BIO2008-01091 from the MICINN to E.E.; and grants from the Instituto de Salud Carlos III FEDER (RD09/0076/00036) and the Xarxa de Bancs de tumors sponsored by the Pla Director d'Oncologia de Catalunya to the MARBiobanc. P.N. is supported by the Instituto de Salud Carlos III and the Departament de Sanitat de la Generalitat de Catalunya. D.P. holds a Juan de Is Cierva grant from the MICINN. N.M.-B. holds a grant from the Fundacion Ramon Areces. C.E. was supported by a fellowship from the DURSI (Generalitat de Catalunya) and Eons Social Europeu (ESF).en
dc.description.statusPeer-revieweden
dc.format.extent8en
dc.identifier.issn1078-8956en
dc.identifier.otherWOS:000299018600033en
dc.identifier.otherPubMed:22138752en
dc.identifier.otherORCID:/0000-0003-0793-6218/work/162948929en
dc.identifier.scopus84855540060en
dc.identifier.urihttps://hdl.handle.net/1885/733796720
dc.language.isoenen
dc.sourceNature Medicineen
dc.subjectTissue-plasminogen activatoren
dc.subjectGene-expressionen
dc.subjectPancreas canceren
dc.subjectCellular senescenceen
dc.subjectUrokinase receptoren
dc.subjectCellsen
dc.subjectMouseen
dc.subjectCpeben
dc.subjectPolyadenylationen
dc.subjectGrowthen
dc.titleKey contribution of CPEB4-mediated translational control to cancer progressionen
dc.typeJournal articleen
dspace.entity.typePublicationen
local.bibliographicCitation.lastpage90en
local.bibliographicCitation.startpage83en
local.contributor.affiliationOrtiz-Zapater, Elena; Hospital del Mar Medical Research Instituteen
local.contributor.affiliationPineda, David; Hospital del Mar Medical Research Instituteen
local.contributor.affiliationMartinez-Bosch, Neus; Hospital del Mar Medical Research Instituteen
local.contributor.affiliationFernandez-Miranda, Gonzalo; Barcelona Institute of Science and Technologyen
local.contributor.affiliationIglesias, Mar; Hospital del Mar Medical Research Instituteen
local.contributor.affiliationAlameda, Francesc; Autonomous University of Barcelonaen
local.contributor.affiliationMoreno, Mireia; Hospital del Mar Medical Research Instituteen
local.contributor.affiliationEliscovich, Carolina; Barcelona Institute of Science and Technologyen
local.contributor.affiliationEyras, Eduardo; Pompeu Fabra Universityen
local.contributor.affiliationReal, Francisco X.; Hospital del Mar Medical Research Instituteen
local.contributor.affiliationMendez, Raul; Barcelona Institute of Science and Technologyen
local.contributor.affiliationNavarro, Pilar; Hospital del Mar Medical Research Instituteen
local.identifier.citationvolume18en
local.identifier.doi10.1038/nm.2540en
local.identifier.purefdcede10-10ef-4d46-80c6-1a2bc4196c95en
local.identifier.urlhttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=anu_research_portal_plus2&SrcAuth=WosAPI&KeyUT=WOS:000299018600033&DestLinkType=FullRecord&DestApp=WOS_CPLen
local.identifier.urlhttps://www.scopus.com/pages/publications/84855540060en
local.type.statusPublisheden

Downloads